Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

Condition:   Treatment of Deep Vein Thrombosis and/or Pulmonary Embolism in Cancer Patients Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Low molecular weight heparin (LMWH);   Drug: Direct Oral Anticoagulants (DOAC) Sponsor:   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials